Mirena® approved in Europe for extended duration of use in contraception

14

October

2022

|

09:30 AM

Europe/Amsterdam

Not intended for U.S. and UK Media

Summary

Mirena® (52mg LNG IUS), Bayer’s long-acting reversible intrauterine system, received regulatory approval in the European Workshare Procedure for up to eight years in contraception, now offering the longest contraceptive duration of use for any hormonal intrauterine system – national approvals expected in Q4 / The IUS is one of the most effective birth control methods / Mirena was also approved for the treatment of idiopathic menorrhagia (heavy menstrual bleeding) for up to eight years if symptoms have not returned earlier 

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Alzheimer's Concerns High; Aducanumab Knowledge Low thumbnail

Alzheimer’s Concerns High; Aducanumab Knowledge Low

Concerns about Alzheimer's disease were high, but knowledge about aducanumab (Aduhelm) was low, survey data found. Among 1,035 older Americans surveyed during a period when media coverage of the FDA's controversial approval of aducanumab was high, 84.9% said they were concerned about Alzheimer's disease, reported Julie Zissimopoulos, PhD, of University of Southern California in Los…
Read More
Serbia: civil society builds bridges between migrants and health workers during the COVID-19 pandemic thumbnail

Serbia: civil society builds bridges between migrants and health workers during the COVID-19 pandemic

Every year, more than 50 000 refugees and migrants pass through Serbia. On arrival, many are physically exhausted, traumatized, and need medical services and assistance.However, migrants on the move often prioritize continuing their journey over caring for their health or getting treatment for serious medical conditions. Although health workers have been encouraging them to take protective…
Read More
System outages reported in some public hospitals, health facilities in Singapore thumbnail

System outages reported in some public hospitals, health facilities in Singapore

Over the past six weeks, system interruptions have been reported in some public hospitals and healthcare facilities under the National Healthcare Group and the National University Health System, leading to delays in appointments and longer wait times. The first reported outage occurred on 27 August; 26 IT applications, including EMR, appointment, pharmacy and laboratory systems
Read More

Acute viral bronchiolitis in a pediatric ICU

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed O Portal PEBMED é destinado para médicos e demais profissionais de saúde. Nossos conteúdos informam panoramas recentes da medicina. Caso tenha interesse em divulgar seu currículo na internet,…
Read More
Check-up Semanal: Janeiro verde e o combate ao câncer de colo do útero, testes rápidos para Covid-19 e mais! thumbnail

Check-up Semanal: Janeiro verde e o combate ao câncer de colo do útero, testes rápidos para Covid-19 e mais!

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed O Portal PEBMED é destinado para médicos e demais profissionais de saúde. Nossos conteúdos informam panoramas recentes da medicina. Caso tenha interesse em divulgar seu currículo na internet,…
Read More
Read This Before You Get Laser Hair Removal thumbnail

Read This Before You Get Laser Hair Removal

If you’re considering zapping off your body hair, you’re probably wondering about laser hair removal pros and cons. Actually, let’s back up first—if bod-hair removal is your thing (it’s totally okay to grow it out, by the way), there are plenty of temporary options at your disposal. You’ve got the classic, quick (and short-lived) shave,…
Read More
Index Of News
Total
0
Share